Suppr超能文献

SSAT 最新进展大会:胃部肿瘤的当前外科治疗管理。

SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.

机构信息

Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

J Gastrointest Surg. 2018 Jan;22(1):32-42. doi: 10.1007/s11605-017-3533-8. Epub 2017 Aug 14.

Abstract

INTRODUCTION

The current era of gastric surgery is marked by low morbidity and mortality rates, innovative strategies to approach resections with a minimally invasive fashion or hyperthermic intraperitoneal chemotherapy (HIPEC), as well as improved understanding of the biology of sporadic and hereditary stromal, neuroendocrine, and epithelial malignancies.

METHODS

In 2017, the Society for Surgery of the Alimentary Tract convened a State-of-the-Art Conference on Current Surgical Management of Gastric Tumors with both international experts and emerging leaders in the field of gastric surgery.

RESULTS

Martin D. McCarter, MD of the University of Colorado discussed the current management of gastric gastrointestinal stromal tumors (GIST). Kaitlyn J. Kelly, MD of the University of California, San Diego discussed the management of gastric carcinoid tumors. Jeffrey A. Norton of Stanford University discussed recent advances in the management of gastric adenocarcinoma including a focus on hereditary diffuse gastric cancer (HDGC). Joseph Kim, MD of Stony Brook University discussed a systematic approach to minimally invasive gastrectomy for cancer. Joyce Wong, MD of Pennsylvania State University discussed the role for cytoreductive surgery (CRS) and HIPEC for gastric adenocarcinoma.

CONCLUSIONS

This review provides gastrointestinal surgeons with a concise update on the current surgical management of gastric tumors.

摘要

简介

当前的胃外科时代以低发病率和死亡率为标志,采用创新策略以微创方式进行切除术或腹腔内热化疗(HIPEC),以及对散发性和遗传性基质、神经内分泌和上皮恶性肿瘤的生物学有了更好的理解。

方法

2017 年,消化道外科学会召集了一次关于当前胃肿瘤外科治疗的最新技术会议,邀请了国际专家和新兴的胃外科学领域的领导者。

结果

科罗拉多大学的 Martin D. McCarter,医学博士讨论了胃胃肠间质瘤(GIST)的当前治疗方法。加利福尼亚大学圣地亚哥分校的 Kaitlyn J. Kelly,医学博士讨论了胃类癌肿瘤的治疗方法。斯坦福大学的 Jeffrey A. Norton 讨论了胃腺癌治疗的最新进展,包括重点关注遗传性弥漫性胃癌(HDGC)。石溪大学的 Joseph Kim,医学博士讨论了癌症微创胃切除术的系统方法。宾夕法尼亚州立大学的 Joyce Wong,医学博士讨论了细胞减灭术(CRS)和 HIPEC 在胃腺癌中的作用。

结论

这篇综述为胃肠外科医生提供了关于胃肿瘤当前外科治疗的简明更新。

相似文献

1
SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.
J Gastrointest Surg. 2018 Jan;22(1):32-42. doi: 10.1007/s11605-017-3533-8. Epub 2017 Aug 14.
4
CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
Ann Surg Oncol. 2016 Nov;23(12):3972-3977. doi: 10.1245/s10434-016-5306-0. Epub 2016 Jun 16.
5
Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
Chirurgia (Bucur). 2017 Nov-Dec;112(6):714-725. doi: 10.21614/chirurgia.112.6.714.

引用本文的文献

1
Trends and Predictors of Failure of Minimally Invasive Surgery for Gastric GIST.
J Gastrointest Surg. 2021 May;25(5):1319-1322. doi: 10.1007/s11605-020-04816-y. Epub 2020 Oct 15.
2
Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Cancer Metastasis Rev. 2019 Sep;38(3):525-535. doi: 10.1007/s10555-019-09818-0.
3
Gastric carcinoid tumor after laparoscopic gastric banding: Case report of a patient with weight regain.
Int J Surg Case Rep. 2018;51:275-276. doi: 10.1016/j.ijscr.2018.08.054. Epub 2018 Sep 4.

本文引用的文献

1
Management of Gastrointestinal Stromal Tumors.
Surg Clin North Am. 2017 Apr;97(2):437-452. doi: 10.1016/j.suc.2016.12.001.
2
Neuroendocrine Tumors of the Stomach.
Surg Clin North Am. 2017 Apr;97(2):333-343. doi: 10.1016/j.suc.2016.11.008. Epub 2017 Mar 3.
3
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.
Expert Rev Mol Diagn. 2017 May;17(5):445-457. doi: 10.1080/14737159.2017.1308826. Epub 2017 Mar 27.
4
Current Progress in the Adjuvant Treatment of Gastric Cancer.
Surg Oncol Clin N Am. 2017 Apr;26(2):225-239. doi: 10.1016/j.soc.2016.10.008. Epub 2017 Feb 14.
6
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
J Transl Med. 2016 Dec 14;14(1):339. doi: 10.1186/s12967-016-1075-6.
8
Management of gastric and duodenal neuroendocrine tumors.
World J Gastroenterol. 2016 Aug 14;22(30):6817-28. doi: 10.3748/wjg.v22.i30.6817.
9
A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
J Surg Oncol. 2016 Oct;114(5):576-580. doi: 10.1002/jso.24369. Epub 2016 Jul 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验